Geographic atrophy disease progression is explored by a panel of medical experts. Ryan Haumschild, PharmD, MS, MBA: Dr Khanani, we’ve discussed geographic atrophy [GA], and you did a great job giving ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Spinal cord ...
Geographic atrophy (GA), the late stage of age-related macular degeneration (AMD), may lead to vision loss. Here’s what to expect as the condition progresses. About 1 million people in the United ...
The study examined patients who were treated with intravitreal anti-vascular endothelial growth factor (anti-VEGF) compounds for their nAMD. A total of 76 patients (92 eyes) were followed for at least ...
Hosted on MSN
Study backs Alterity’s innovative tool in diagnosing and monitoring MSA disease progression
Quality peer-reviewed publication highlights use of Alterity’s MSA Atrophy Index developed to diagnose and track MSA disease progression Tool helps pinpoint changes in brain over time, making it ...
HONOLULU — A novel “moderate-affinity iron chaperone” known as ATH434 (Alterity Therapeutics) may slow disease progression in patients with multiple system atrophy (MSA), new research suggested. The ...
VALBY, Denmark, May 8, 2025 /PRNewswire/ -- H. Lundbeck A/S (Lundbeck) will present key pipeline data and patient perspectives from the phase II AMULET trial, investigating amlenetug as a potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results